Macleods Pharmaceuticals
Ticker > Company >

Macleods Pharmaceuticals share price

Macleods Pharmaceuticals Ltd.

 4.38 K   0   0

The company is currently not listed and is under IPO, so all the data might not be available.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Ratios

Sales Growth

1 Year7.38%
3 Year6.41%
5 Year6.41%

Profit Growth

1 Year11.25%
3 Year24.94%
5 Year4.18%

ROE%

1 Year22.58%
3 Year24.13%
5 Year26.49%

ROCE %

1 Year23.04%
3 Year25.68%
5 Year30.46%

Debt/Equity

0.029

Price to Cash Flow

0

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

 Strengths

  • Company has been maintaining healthy ROE of 24.1250518059243% over the past 3 years.
  • Company has been maintaining healthy ROCE of 25.6792408657137% over the past 3 years.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 0 days.
  • The company has a high promoter holding of 100%.
  • Promoter stake has increased from 0% to 100% in the last 1 quarter.

 Limitations

  • The company has shown a poor revenue growth of 6.40866135189662% for the Past 3 years.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 7014.11 7462.67 7813.3 8373.18 8991.37
Total Expenditure 4670.54 5903.28 6381.99 6239.62 6745.19
Operating Profit 2343.56 1559.38 1431.31 2133.56 2246.18
Other Income 544.64 125.82 213.34 499.41 316.74
Interest 5.84 10.81 7.43 11.61 8.54
Depreciation 132.13 156.55 169.85 163.86 172.88
Exceptional Items 0 0 0 0 0
Profit Before Tax 2750.23 1517.84 1467.37 2457.5 2381.5
Tax 533.91 350.61 -8.02 411.29 105.13
Net Profit 2216.33 1167.23 1475.39 2046.21 2276.37
Adjusted EPS (Rs.) 37.01 19.49 24.64 31.54 35.09

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 19.96 59.88 59.88 64.87 64.87
Total Reserves 4226.69 5353.38 6840.29 8877.05 11157.09
Borrowings 0 0 0 0 0.04
Other N/C liabilities -356.33 -298.23 -542.95 -379.48 -618.76
Current liabilities 1428.64 1324.91 1537.23 4063.84 2731.17
Total Liabilities 5318.96 6439.94 7894.45 12626.28 13334.41
Assets
Net Block 1399.64 1473.42 1618.99 1627.62 1766.33
Capital WIP 252.75 334.34 189.93 287.44 526.71
Intangible WIP 0 0 0 0 0
Investments 16.93 234.76 438.53 1688.86 1676.06
Loans & Advances 123.88 89.94 89.96 97.23 101.86
Other N/C Assets 220.6 771.75 546.2 793.94 509.56
Current Assets 3305.17 3535.73 5010.85 8131.19 8753.89
Total Assets 5318.96 6439.94 7894.45 12626.28 13334.41
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 2750.23 1517.84 1467.37 2457.5 2381.5
Adjustment -343 113.05 98.35 -274.51 13.92
Changes in Assets & Liabilities -654.3 95.14 664.11 -651.53 -239.19
Tax Paid -477.54 -314.77 -228.77 -341.18 -398.48
Operating Cash Flow 1275.39 1411.25 2001.06 1190.28 1757.75
Investing Cash Flow -1330.74 -1400.17 -2067.06 -1269.13 -1845.74
Financing Cash Flow 30.46 -21.12 95.36 104.74 48.48
Net Cash Flow -24.89 -10.04 29.36 25.89 -39.51

Corporate Actions

Company News

 No Latest News available for this company.Report us
Last Updated on:
Brief about Macleods Pharmaceuticals
X